Artificial Pancreas Improves Blood Sugar Control in Type 1 Diabetes

An artificial pancreas can improve blood sugar control for people with type 1 diabetes (T1D), according to a new study.

Researchers from the Aristotle University of Thessaloniki, Greece, reported Wednesday that an artificial pancreas can provide nearly 2.5 extra hours of daily normal blood glucose levels (normoglycemia). At the same time, it could also reduce time of both hyperglycemia and hypoglycemia levels.

Using a continuous glucose monitoring (CGM) device to measure blood sugar levels and transmit information to a calculating insulin pump that releases required levels of insulin into the body, the artificial pancreas has the potential to fulfill the entire duties of that of a real one in patients with diabetes.

Researchers, led by Dr. Eleni Bekiari, reviewed the results of 41 randomized controlled trials which involved an accumulated 1000-plus patients with T1D, comparing artificial pancreas systems with other insulin-based devices — including insulin pump therapy.

Click to continue reading on MD Magazine.